Fol­low­ing can­cer com­bo deal with Bris­tol-My­ers, Taris gets $25M Se­ries B

Just one day af­ter an­nounc­ing a can­cer com­bo col­lab­o­ra­tion with Bris­tol-My­ers Squibb, Taris Bio­med­ical has raised $25 mil­lion in a new Se­ries B round backed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER